SlideShare a Scribd company logo
1 of 13
Download to read offline
Courtney Hudson, CEO & Founder, EmergingMedJune 26, 2017
FACT VS FICTION:
CLINICAL TRIALS FOR OVARIAN CANCER
FACT vs. FICTION
CLINICAL TRIALS FOR BREAST CANCER
Agenda
1. How to search for clinical trials?
2. What’s out there?
3. About targeted therapies & tumor
profiling
4. Considerations for phase I clinical trials
5. Discussion & questions
2
www.ShareCancerSupport.org 1.877.769.4832
Today’s goal is to empower you with information
and a strategy to explore and access breast
cancer clinical trials
Create a profile team up with a Navigator
How to search for trials?3
www.ShareCancerSupport.org 1.877.769.4832
SHARE Clinical Trial Matching Service
4
www.ShareCancerSupport.org 1.877.769.4832
1) Complete profile
2) Update profile
3) Review matches with
Clinical Trial Navigator
4) Talk to trial site(s)
5) Discuss with your doctor
Never forget...
¨ Clinical trials may or may not be right for you
v Standard care vs. clinical trial vs. off label treatment vs. watch & wait
¨ Explore clinical trials each time you make a treatment
decision
¨ You are NEVER required to enroll in a clinical trial
¨ You are NEVER required to remain in a clinical trial
after you enroll
5
www.ShareCancerSupport.org 1.877.769.4832
Clinical trials measure, measure, measure
6
LESSONS Childhood Leukemia
LEARNED Breast Cancer– BMT & HDC
¨ Clinical trials explore risk/benefit of new therapies:
v New drug OR combination OR dosage/sequence
¨ Is experimental therapy better/worse vs. standard placebo
¨ Phases: I, II, III have become I/II, II, II/III, etc.
¨ Eligibility:
v Diagnosis, stage, treatment history
v And now tumor biomarkers…Tomorrow?
¨ Interim analysis
Notes
Clinical trials expect you to receive
standard of care (vs. off label)
Narrow window of time to enroll
What’s out there for metastatic breast
cancer treatment trials? as of 6/23/2017
7
www.ShareCancerSupport.org 1.877.769.4832
Ø 50 unique drugs
Ø 25 targeted agents (hitting 40 alterations)
Ø 16 chemotherapies
Ø 9 hormonal therapies
Ø 2 immunotherapies target PD1 and PDL1
261 studies for metastatic breast cancer
www.ShareCancerSupport.org 1.877.769.4832
Clinical trials offered at all points
(newly diagnosed --> many treatments)
9
About targeted therapies & genomic profiling
¨ Identify biomarkers or genomic alterations specific to
your tumor
¨ May or may not point you to a clinical trial today
¨ May provide information useful to you tomorrow
v Check back periodically for new research and targeted
agents specific to your tumor’s molecular or genetic profile
v Big question: do tumor’s change over time?
www.ShareCancerSupport.org 1.877.769.4832
10
Ø Phase I trials are the first time a new therapy,
a new combination, or a new dosage schedule
is offered to patients
Ø Hundreds of new targeted therapies and
immunotherapies are entering Phase I trials
Ø These new opportunities raise new questions
Considerations for Phase I Trials11
www.ShareCancerSupport.org 1.877.769.4832
Phase I, first-in-human trials & targeted therapies
12
¨ Anti-cancer activity is now a goal in Phase I trials
v Safety &maximum dose used to be only focus
¨ 70% of all agents in Phase I move on to Phase II
v In 2000, only 10% moved on to Phase II trials
¨ Over 700 new agents in Phase I cancer studies today
v Only 45 specifically mention ovarian cancer
v Look for roll over studies: Phase I/II or II/III
v May need to become patient of the investigator to get enrolled
in a Phase I trial (limited openings, limited sites)
¨ Always ask: how many patients have had the new therapy before
you in a Phase I study (none? 1? 10? 100?)
www.ShareCancerSupport.org 1.877.769.4832
Courtney Hudson
CEO & Founder, EmergingMed
chudson@emergingmed.com
To search for trials and get registered:
www.ShareCancerSupport.org
1.877.769.4832
Thank you and good luck13

More Related Content

What's hot

Report Back from ASCO on Metastatic Breast Cancer
Report Back from ASCO on Metastatic Breast CancerReport Back from ASCO on Metastatic Breast Cancer
Report Back from ASCO on Metastatic Breast Cancerbkling
 
Invasive Lobular Carcinoma — Highlights from the First Ever ILC Symposium
Invasive Lobular Carcinoma — Highlights from the First Ever ILC Symposium Invasive Lobular Carcinoma — Highlights from the First Ever ILC Symposium
Invasive Lobular Carcinoma — Highlights from the First Ever ILC Symposium bkling
 
Immunotherapy Update for Ovarian Cancer
Immunotherapy Update for Ovarian Cancer Immunotherapy Update for Ovarian Cancer
Immunotherapy Update for Ovarian Cancer bkling
 
Moving Beyond Resistance: Current Research in ER+ Metastatic Breast Cancer
Moving Beyond Resistance: Current Research in ER+ Metastatic Breast Cancer Moving Beyond Resistance: Current Research in ER+ Metastatic Breast Cancer
Moving Beyond Resistance: Current Research in ER+ Metastatic Breast Cancer Dana-Farber Cancer Institute
 
Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!
Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!
Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!National Ovarian Cancer Coalition
 
Ovarian Cancer Maintenance Therapies
Ovarian Cancer Maintenance TherapiesOvarian Cancer Maintenance Therapies
Ovarian Cancer Maintenance Therapiesbkling
 
What’s New in Biology, Treatment and Clinical Trials for Metastatic Triple-N...
What’s New in Biology, Treatment  and Clinical Trials for Metastatic Triple-N...What’s New in Biology, Treatment  and Clinical Trials for Metastatic Triple-N...
What’s New in Biology, Treatment and Clinical Trials for Metastatic Triple-N...Dana-Farber Cancer Institute
 
Living with Advanced Breast Cancer: Challenges and Opportunities
Living with Advanced Breast Cancer: Challenges and OpportunitiesLiving with Advanced Breast Cancer: Challenges and Opportunities
Living with Advanced Breast Cancer: Challenges and Opportunitiesbkling
 
Topic-Driven Round Table on Low Grade Serous Ovarian Cancer
Topic-Driven Round Table on Low Grade Serous Ovarian CancerTopic-Driven Round Table on Low Grade Serous Ovarian Cancer
Topic-Driven Round Table on Low Grade Serous Ovarian Cancerbkling
 
SHARE: Metastatic Breast Cancer: Cutting-Edge Research from National Cancer w...
SHARE: Metastatic Breast Cancer: Cutting-Edge Research from National Cancer w...SHARE: Metastatic Breast Cancer: Cutting-Edge Research from National Cancer w...
SHARE: Metastatic Breast Cancer: Cutting-Edge Research from National Cancer w...bkling
 
DCIS Topic-Driven Round Table: Decision-Making and Treatment Choices
DCIS Topic-Driven Round Table: Decision-Making and Treatment ChoicesDCIS Topic-Driven Round Table: Decision-Making and Treatment Choices
DCIS Topic-Driven Round Table: Decision-Making and Treatment Choicesbkling
 
Primary Prevention: A National Call to Action - Dr. Jeff Gershenwald
Primary Prevention: A National Call to Action - Dr. Jeff GershenwaldPrimary Prevention: A National Call to Action - Dr. Jeff Gershenwald
Primary Prevention: A National Call to Action - Dr. Jeff GershenwaldMelanoma Research Foundation
 
Gi Cancer Symposium 2012 Report Presentation
Gi Cancer Symposium 2012 Report PresentationGi Cancer Symposium 2012 Report Presentation
Gi Cancer Symposium 2012 Report PresentationFight Colorectal Cancer
 
Impact of Multidisciplinary Discussion on Treatment Outcome For Gynecologic C...
Impact of Multidisciplinary Discussion on Treatment Outcome For Gynecologic C...Impact of Multidisciplinary Discussion on Treatment Outcome For Gynecologic C...
Impact of Multidisciplinary Discussion on Treatment Outcome For Gynecologic C...Emad Shash
 
Communities of Color and Participation in Breast Cancer Research
Communities of Color and Participation in Breast Cancer ResearchCommunities of Color and Participation in Breast Cancer Research
Communities of Color and Participation in Breast Cancer Researchbkling
 

What's hot (20)

Report Back from ASCO on Metastatic Breast Cancer
Report Back from ASCO on Metastatic Breast CancerReport Back from ASCO on Metastatic Breast Cancer
Report Back from ASCO on Metastatic Breast Cancer
 
Invasive Lobular Carcinoma — Highlights from the First Ever ILC Symposium
Invasive Lobular Carcinoma — Highlights from the First Ever ILC Symposium Invasive Lobular Carcinoma — Highlights from the First Ever ILC Symposium
Invasive Lobular Carcinoma — Highlights from the First Ever ILC Symposium
 
Immunotherapy Update for Ovarian Cancer
Immunotherapy Update for Ovarian Cancer Immunotherapy Update for Ovarian Cancer
Immunotherapy Update for Ovarian Cancer
 
Moving Beyond Resistance: Current Research in ER+ Metastatic Breast Cancer
Moving Beyond Resistance: Current Research in ER+ Metastatic Breast Cancer Moving Beyond Resistance: Current Research in ER+ Metastatic Breast Cancer
Moving Beyond Resistance: Current Research in ER+ Metastatic Breast Cancer
 
Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!
Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!
Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!
 
Ovarian Cancer Maintenance Therapies
Ovarian Cancer Maintenance TherapiesOvarian Cancer Maintenance Therapies
Ovarian Cancer Maintenance Therapies
 
NCCN Guidelines for Patients: Ovarian Cancer
NCCN Guidelines for Patients: Ovarian CancerNCCN Guidelines for Patients: Ovarian Cancer
NCCN Guidelines for Patients: Ovarian Cancer
 
What’s New in Biology, Treatment and Clinical Trials for Metastatic Triple-N...
What’s New in Biology, Treatment  and Clinical Trials for Metastatic Triple-N...What’s New in Biology, Treatment  and Clinical Trials for Metastatic Triple-N...
What’s New in Biology, Treatment and Clinical Trials for Metastatic Triple-N...
 
Living with Advanced Breast Cancer: Challenges and Opportunities
Living with Advanced Breast Cancer: Challenges and OpportunitiesLiving with Advanced Breast Cancer: Challenges and Opportunities
Living with Advanced Breast Cancer: Challenges and Opportunities
 
Topic-Driven Round Table on Low Grade Serous Ovarian Cancer
Topic-Driven Round Table on Low Grade Serous Ovarian CancerTopic-Driven Round Table on Low Grade Serous Ovarian Cancer
Topic-Driven Round Table on Low Grade Serous Ovarian Cancer
 
SHARE: Metastatic Breast Cancer: Cutting-Edge Research from National Cancer w...
SHARE: Metastatic Breast Cancer: Cutting-Edge Research from National Cancer w...SHARE: Metastatic Breast Cancer: Cutting-Edge Research from National Cancer w...
SHARE: Metastatic Breast Cancer: Cutting-Edge Research from National Cancer w...
 
When Cancer Comes Back, Sarah Adams, MD
When Cancer Comes Back, Sarah Adams, MDWhen Cancer Comes Back, Sarah Adams, MD
When Cancer Comes Back, Sarah Adams, MD
 
DCIS Topic-Driven Round Table: Decision-Making and Treatment Choices
DCIS Topic-Driven Round Table: Decision-Making and Treatment ChoicesDCIS Topic-Driven Round Table: Decision-Making and Treatment Choices
DCIS Topic-Driven Round Table: Decision-Making and Treatment Choices
 
Primary Prevention: A National Call to Action - Dr. Jeff Gershenwald
Primary Prevention: A National Call to Action - Dr. Jeff GershenwaldPrimary Prevention: A National Call to Action - Dr. Jeff Gershenwald
Primary Prevention: A National Call to Action - Dr. Jeff Gershenwald
 
Imaging After Breast Cancer
Imaging After Breast CancerImaging After Breast Cancer
Imaging After Breast Cancer
 
Gi Cancer Symposium 2012 Report Presentation
Gi Cancer Symposium 2012 Report PresentationGi Cancer Symposium 2012 Report Presentation
Gi Cancer Symposium 2012 Report Presentation
 
Discover Personalized Medicine: Setsuko Chambers, MD
Discover Personalized Medicine: Setsuko Chambers, MD Discover Personalized Medicine: Setsuko Chambers, MD
Discover Personalized Medicine: Setsuko Chambers, MD
 
Impact of Multidisciplinary Discussion on Treatment Outcome For Gynecologic C...
Impact of Multidisciplinary Discussion on Treatment Outcome For Gynecologic C...Impact of Multidisciplinary Discussion on Treatment Outcome For Gynecologic C...
Impact of Multidisciplinary Discussion on Treatment Outcome For Gynecologic C...
 
Newly Diagnosed, Stephanie Wethington, MD
Newly Diagnosed, Stephanie Wethington, MDNewly Diagnosed, Stephanie Wethington, MD
Newly Diagnosed, Stephanie Wethington, MD
 
Communities of Color and Participation in Breast Cancer Research
Communities of Color and Participation in Breast Cancer ResearchCommunities of Color and Participation in Breast Cancer Research
Communities of Color and Participation in Breast Cancer Research
 

Viewers also liked

Strategies for Long-term Management of Recurrent Ovarian Cancer
Strategies for Long-term Management of Recurrent Ovarian CancerStrategies for Long-term Management of Recurrent Ovarian Cancer
Strategies for Long-term Management of Recurrent Ovarian Cancerbkling
 
New Developments in Breast Reconstruction Surgery
New Developments in Breast Reconstruction SurgeryNew Developments in Breast Reconstruction Surgery
New Developments in Breast Reconstruction Surgerybkling
 
Facing Forward: When Cancer Changes the Road Ahead
Facing Forward: When Cancer Changes the Road AheadFacing Forward: When Cancer Changes the Road Ahead
Facing Forward: When Cancer Changes the Road Aheadbkling
 
Metastatic Breast Cancer Awareness Day: Special Event Webinar
Metastatic Breast Cancer Awareness Day: Special Event WebinarMetastatic Breast Cancer Awareness Day: Special Event Webinar
Metastatic Breast Cancer Awareness Day: Special Event Webinarbkling
 
Tumor Dormancy
Tumor DormancyTumor Dormancy
Tumor Dormancybkling
 
Patient Perspective on Strategies for Long-Term Management of Recurrent Ovari...
Patient Perspective on Strategies for Long-Term Management of Recurrent Ovari...Patient Perspective on Strategies for Long-Term Management of Recurrent Ovari...
Patient Perspective on Strategies for Long-Term Management of Recurrent Ovari...bkling
 
Difficult Conversations: Bridging the Communication Gap with your Oncologist
Difficult Conversations: Bridging the Communication Gap with your OncologistDifficult Conversations: Bridging the Communication Gap with your Oncologist
Difficult Conversations: Bridging the Communication Gap with your Oncologistbkling
 
The family center disability webinar for share sept 2017
The family center   disability webinar for share sept 2017The family center   disability webinar for share sept 2017
The family center disability webinar for share sept 2017bkling
 
Your Sexuality After Cancer
Your Sexuality After CancerYour Sexuality After Cancer
Your Sexuality After Cancerbkling
 
Side Effects Management for the Ovarian Cancer Community
Side Effects Management for the Ovarian Cancer CommunitySide Effects Management for the Ovarian Cancer Community
Side Effects Management for the Ovarian Cancer Communitybkling
 

Viewers also liked (10)

Strategies for Long-term Management of Recurrent Ovarian Cancer
Strategies for Long-term Management of Recurrent Ovarian CancerStrategies for Long-term Management of Recurrent Ovarian Cancer
Strategies for Long-term Management of Recurrent Ovarian Cancer
 
New Developments in Breast Reconstruction Surgery
New Developments in Breast Reconstruction SurgeryNew Developments in Breast Reconstruction Surgery
New Developments in Breast Reconstruction Surgery
 
Facing Forward: When Cancer Changes the Road Ahead
Facing Forward: When Cancer Changes the Road AheadFacing Forward: When Cancer Changes the Road Ahead
Facing Forward: When Cancer Changes the Road Ahead
 
Metastatic Breast Cancer Awareness Day: Special Event Webinar
Metastatic Breast Cancer Awareness Day: Special Event WebinarMetastatic Breast Cancer Awareness Day: Special Event Webinar
Metastatic Breast Cancer Awareness Day: Special Event Webinar
 
Tumor Dormancy
Tumor DormancyTumor Dormancy
Tumor Dormancy
 
Patient Perspective on Strategies for Long-Term Management of Recurrent Ovari...
Patient Perspective on Strategies for Long-Term Management of Recurrent Ovari...Patient Perspective on Strategies for Long-Term Management of Recurrent Ovari...
Patient Perspective on Strategies for Long-Term Management of Recurrent Ovari...
 
Difficult Conversations: Bridging the Communication Gap with your Oncologist
Difficult Conversations: Bridging the Communication Gap with your OncologistDifficult Conversations: Bridging the Communication Gap with your Oncologist
Difficult Conversations: Bridging the Communication Gap with your Oncologist
 
The family center disability webinar for share sept 2017
The family center   disability webinar for share sept 2017The family center   disability webinar for share sept 2017
The family center disability webinar for share sept 2017
 
Your Sexuality After Cancer
Your Sexuality After CancerYour Sexuality After Cancer
Your Sexuality After Cancer
 
Side Effects Management for the Ovarian Cancer Community
Side Effects Management for the Ovarian Cancer CommunitySide Effects Management for the Ovarian Cancer Community
Side Effects Management for the Ovarian Cancer Community
 

Similar to Clinical Trials for Metastatic Breast Cancer

Clinical Trials: Fact vs. Fiction, Courtney Hudson, CEO & Co-Founder, Emergin...
Clinical Trials: Fact vs. Fiction, Courtney Hudson, CEO & Co-Founder, Emergin...Clinical Trials: Fact vs. Fiction, Courtney Hudson, CEO & Co-Founder, Emergin...
Clinical Trials: Fact vs. Fiction, Courtney Hudson, CEO & Co-Founder, Emergin...Ovarian Cancer Research Fund Alliance
 
Patient engagement in clinical trials
Patient engagement in clinical trials Patient engagement in clinical trials
Patient engagement in clinical trials Martin Kelly
 
Novel Approaches to Clinical Trial Design and Implementation
Novel Approaches to Clinical Trial Design and ImplementationNovel Approaches to Clinical Trial Design and Implementation
Novel Approaches to Clinical Trial Design and Implementationijtsrd
 
Clinical genomics spx
Clinical genomics   spxClinical genomics   spx
Clinical genomics spxDiane McKenna
 
Dr Colin Gaynor - Project managers as truth seekers - it's in our DNA
Dr Colin Gaynor - Project managers as truth seekers - it's in our DNADr Colin Gaynor - Project managers as truth seekers - it's in our DNA
Dr Colin Gaynor - Project managers as truth seekers - it's in our DNAAssociation for Project Management
 
DIA China Making Every Patient Count
DIA China Making Every Patient CountDIA China Making Every Patient Count
DIA China Making Every Patient CountE. Dennis Bashaw
 
Transforming Drug Development at Lilly
Transforming Drug Development at LillyTransforming Drug Development at Lilly
Transforming Drug Development at LillyRahlyn Gossen
 
white-paper-innovation-clinical-trials
white-paper-innovation-clinical-trialswhite-paper-innovation-clinical-trials
white-paper-innovation-clinical-trialsUlrich Neumann, FRSA
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer ScreeningJohnJulie1
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer ScreeningAnonIshanvi
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer ScreeningEditorSara
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer ScreeningNainaAnon
 
Oncology Clinical Development Challenges and Opportunities in the Phase 1 Set...
Oncology Clinical Development Challenges and Opportunities in the Phase 1 Set...Oncology Clinical Development Challenges and Opportunities in the Phase 1 Set...
Oncology Clinical Development Challenges and Opportunities in the Phase 1 Set...Roberto Lara
 
Working with patients to support transformational healthcare
Working with patients to support transformational healthcareWorking with patients to support transformational healthcare
Working with patients to support transformational healthcareHealth Innovation Wessex
 
Canada’s Orphan Drug Regulatory Framework & panCanadian Access to Rare Diseas...
Canada’s Orphan Drug Regulatory Framework & panCanadian Access to Rare Diseas...Canada’s Orphan Drug Regulatory Framework & panCanadian Access to Rare Diseas...
Canada’s Orphan Drug Regulatory Framework & panCanadian Access to Rare Diseas...Canadian Organization for Rare Disorders
 
Global breast cancer vaccine clinical trial insight
Global breast cancer vaccine clinical trial insightGlobal breast cancer vaccine clinical trial insight
Global breast cancer vaccine clinical trial insightKuicK Research
 

Similar to Clinical Trials for Metastatic Breast Cancer (20)

Clinical Trials: Fact vs. Fiction, Courtney Hudson, CEO & Co-Founder, Emergin...
Clinical Trials: Fact vs. Fiction, Courtney Hudson, CEO & Co-Founder, Emergin...Clinical Trials: Fact vs. Fiction, Courtney Hudson, CEO & Co-Founder, Emergin...
Clinical Trials: Fact vs. Fiction, Courtney Hudson, CEO & Co-Founder, Emergin...
 
Patient engagement in clinical trials
Patient engagement in clinical trials Patient engagement in clinical trials
Patient engagement in clinical trials
 
Novel Approaches to Clinical Trial Design and Implementation
Novel Approaches to Clinical Trial Design and ImplementationNovel Approaches to Clinical Trial Design and Implementation
Novel Approaches to Clinical Trial Design and Implementation
 
Clinical genomics spx
Clinical genomics   spxClinical genomics   spx
Clinical genomics spx
 
Dr Colin Gaynor - Project managers as truth seekers - it's in our DNA
Dr Colin Gaynor - Project managers as truth seekers - it's in our DNADr Colin Gaynor - Project managers as truth seekers - it's in our DNA
Dr Colin Gaynor - Project managers as truth seekers - it's in our DNA
 
DIA China Making Every Patient Count
DIA China Making Every Patient CountDIA China Making Every Patient Count
DIA China Making Every Patient Count
 
Transforming Drug Development at Lilly
Transforming Drug Development at LillyTransforming Drug Development at Lilly
Transforming Drug Development at Lilly
 
Ourotech slide deck
Ourotech slide deckOurotech slide deck
Ourotech slide deck
 
white-paper-innovation-clinical-trials
white-paper-innovation-clinical-trialswhite-paper-innovation-clinical-trials
white-paper-innovation-clinical-trials
 
Clinical research
Clinical researchClinical research
Clinical research
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer Screening
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer Screening
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer Screening
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer Screening
 
Oncology Clinical Development Challenges and Opportunities in the Phase 1 Set...
Oncology Clinical Development Challenges and Opportunities in the Phase 1 Set...Oncology Clinical Development Challenges and Opportunities in the Phase 1 Set...
Oncology Clinical Development Challenges and Opportunities in the Phase 1 Set...
 
Working with patients to support transformational healthcare
Working with patients to support transformational healthcareWorking with patients to support transformational healthcare
Working with patients to support transformational healthcare
 
Canada’s Orphan Drug Regulatory Framework & panCanadian Access to Rare Diseas...
Canada’s Orphan Drug Regulatory Framework & panCanadian Access to Rare Diseas...Canada’s Orphan Drug Regulatory Framework & panCanadian Access to Rare Diseas...
Canada’s Orphan Drug Regulatory Framework & panCanadian Access to Rare Diseas...
 
Global breast cancer vaccine clinical trial insight
Global breast cancer vaccine clinical trial insightGlobal breast cancer vaccine clinical trial insight
Global breast cancer vaccine clinical trial insight
 
Ourotech Investor Deck Feb 2017
Ourotech Investor Deck Feb 2017Ourotech Investor Deck Feb 2017
Ourotech Investor Deck Feb 2017
 
0405 Bettina Rryll - The clinical trials we want!
0405  Bettina Rryll - The clinical trials we want! 0405  Bettina Rryll - The clinical trials we want!
0405 Bettina Rryll - The clinical trials we want!
 

More from bkling

Advocating for Better Outcomes: Ovarian Cancer and You
Advocating for Better Outcomes: Ovarian Cancer and YouAdvocating for Better Outcomes: Ovarian Cancer and You
Advocating for Better Outcomes: Ovarian Cancer and Youbkling
 
Embracing Life's Balancing Act - Part 1
Embracing Life's Balancing Act  - Part 1Embracing Life's Balancing Act  - Part 1
Embracing Life's Balancing Act - Part 1bkling
 
Embracing Life's Balancing Act: Part 2 - Fall Action Plan
Embracing Life's Balancing Act: Part 2 - Fall Action PlanEmbracing Life's Balancing Act: Part 2 - Fall Action Plan
Embracing Life's Balancing Act: Part 2 - Fall Action Planbkling
 
Let's Talk About It: Communication, Intimacy, and Sex… Oh My!
Let's Talk About It: Communication, Intimacy, and Sex… Oh My!Let's Talk About It: Communication, Intimacy, and Sex… Oh My!
Let's Talk About It: Communication, Intimacy, and Sex… Oh My!bkling
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?bkling
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
 
Learn Tips for Managing Chemobrain or Mental Fogginess
Learn Tips for Managing Chemobrain or Mental FogginessLearn Tips for Managing Chemobrain or Mental Fogginess
Learn Tips for Managing Chemobrain or Mental Fogginessbkling
 
Vaccines: Will they become a form of Secondary and Primary Breast Cancer Prev...
Vaccines: Will they become a form of Secondary and Primary Breast Cancer Prev...Vaccines: Will they become a form of Secondary and Primary Breast Cancer Prev...
Vaccines: Will they become a form of Secondary and Primary Breast Cancer Prev...bkling
 
Let's Talk About It: Uterine Cancer (Advance Care Planning)
Let's Talk About It: Uterine Cancer (Advance Care Planning)Let's Talk About It: Uterine Cancer (Advance Care Planning)
Let's Talk About It: Uterine Cancer (Advance Care Planning)bkling
 
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...bkling
 
Understanding and Managing Chemo-Induced Peripheral Neuropathy (CIPN)
Understanding and Managing Chemo-Induced Peripheral Neuropathy (CIPN)Understanding and Managing Chemo-Induced Peripheral Neuropathy (CIPN)
Understanding and Managing Chemo-Induced Peripheral Neuropathy (CIPN)bkling
 
Let's Talk About It: Sick and Tired of Being Sick and Tired
Let's Talk About It: Sick and Tired of Being Sick and TiredLet's Talk About It: Sick and Tired of Being Sick and Tired
Let's Talk About It: Sick and Tired of Being Sick and Tiredbkling
 
What’s New with PARP Inhibitors and Ovarian Cancer?
What’s New with PARP Inhibitors and Ovarian Cancer?What’s New with PARP Inhibitors and Ovarian Cancer?
What’s New with PARP Inhibitors and Ovarian Cancer?bkling
 
Caring for You: The Mental & Emotional Toll of Survivorship
Caring for You: The Mental & Emotional Toll of SurvivorshipCaring for You: The Mental & Emotional Toll of Survivorship
Caring for You: The Mental & Emotional Toll of Survivorshipbkling
 
Let's Talk About It: Ovarian Cancer (Shifting Focus: The Relationship with Yo...
Let's Talk About It: Ovarian Cancer (Shifting Focus: The Relationship with Yo...Let's Talk About It: Ovarian Cancer (Shifting Focus: The Relationship with Yo...
Let's Talk About It: Ovarian Cancer (Shifting Focus: The Relationship with Yo...bkling
 
Ways to Manage Ovarian Cancer Treatment Side Effects
Ways to Manage Ovarian Cancer Treatment Side EffectsWays to Manage Ovarian Cancer Treatment Side Effects
Ways to Manage Ovarian Cancer Treatment Side Effectsbkling
 
Part II: DCIS Research: De-escalating the Fear of Recurrence
Part II: DCIS Research: De-escalating the Fear of RecurrencePart II: DCIS Research: De-escalating the Fear of Recurrence
Part II: DCIS Research: De-escalating the Fear of Recurrencebkling
 
Report Back from San Antonio Breast Cancer Symposium (SABCS) 2023: Spotlight ...
Report Back from San Antonio Breast Cancer Symposium (SABCS) 2023: Spotlight ...Report Back from San Antonio Breast Cancer Symposium (SABCS) 2023: Spotlight ...
Report Back from San Antonio Breast Cancer Symposium (SABCS) 2023: Spotlight ...bkling
 
Sharing Our Own Experience- A Qualitative Study with Black Women Diagnosed wi...
Sharing Our Own Experience- A Qualitative Study with Black Women Diagnosed wi...Sharing Our Own Experience- A Qualitative Study with Black Women Diagnosed wi...
Sharing Our Own Experience- A Qualitative Study with Black Women Diagnosed wi...bkling
 
Part I: Not all DCIS is "Risky"
Part I: Not all DCIS is "Risky"Part I: Not all DCIS is "Risky"
Part I: Not all DCIS is "Risky"bkling
 

More from bkling (20)

Advocating for Better Outcomes: Ovarian Cancer and You
Advocating for Better Outcomes: Ovarian Cancer and YouAdvocating for Better Outcomes: Ovarian Cancer and You
Advocating for Better Outcomes: Ovarian Cancer and You
 
Embracing Life's Balancing Act - Part 1
Embracing Life's Balancing Act  - Part 1Embracing Life's Balancing Act  - Part 1
Embracing Life's Balancing Act - Part 1
 
Embracing Life's Balancing Act: Part 2 - Fall Action Plan
Embracing Life's Balancing Act: Part 2 - Fall Action PlanEmbracing Life's Balancing Act: Part 2 - Fall Action Plan
Embracing Life's Balancing Act: Part 2 - Fall Action Plan
 
Let's Talk About It: Communication, Intimacy, and Sex… Oh My!
Let's Talk About It: Communication, Intimacy, and Sex… Oh My!Let's Talk About It: Communication, Intimacy, and Sex… Oh My!
Let's Talk About It: Communication, Intimacy, and Sex… Oh My!
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
 
Learn Tips for Managing Chemobrain or Mental Fogginess
Learn Tips for Managing Chemobrain or Mental FogginessLearn Tips for Managing Chemobrain or Mental Fogginess
Learn Tips for Managing Chemobrain or Mental Fogginess
 
Vaccines: Will they become a form of Secondary and Primary Breast Cancer Prev...
Vaccines: Will they become a form of Secondary and Primary Breast Cancer Prev...Vaccines: Will they become a form of Secondary and Primary Breast Cancer Prev...
Vaccines: Will they become a form of Secondary and Primary Breast Cancer Prev...
 
Let's Talk About It: Uterine Cancer (Advance Care Planning)
Let's Talk About It: Uterine Cancer (Advance Care Planning)Let's Talk About It: Uterine Cancer (Advance Care Planning)
Let's Talk About It: Uterine Cancer (Advance Care Planning)
 
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...
 
Understanding and Managing Chemo-Induced Peripheral Neuropathy (CIPN)
Understanding and Managing Chemo-Induced Peripheral Neuropathy (CIPN)Understanding and Managing Chemo-Induced Peripheral Neuropathy (CIPN)
Understanding and Managing Chemo-Induced Peripheral Neuropathy (CIPN)
 
Let's Talk About It: Sick and Tired of Being Sick and Tired
Let's Talk About It: Sick and Tired of Being Sick and TiredLet's Talk About It: Sick and Tired of Being Sick and Tired
Let's Talk About It: Sick and Tired of Being Sick and Tired
 
What’s New with PARP Inhibitors and Ovarian Cancer?
What’s New with PARP Inhibitors and Ovarian Cancer?What’s New with PARP Inhibitors and Ovarian Cancer?
What’s New with PARP Inhibitors and Ovarian Cancer?
 
Caring for You: The Mental & Emotional Toll of Survivorship
Caring for You: The Mental & Emotional Toll of SurvivorshipCaring for You: The Mental & Emotional Toll of Survivorship
Caring for You: The Mental & Emotional Toll of Survivorship
 
Let's Talk About It: Ovarian Cancer (Shifting Focus: The Relationship with Yo...
Let's Talk About It: Ovarian Cancer (Shifting Focus: The Relationship with Yo...Let's Talk About It: Ovarian Cancer (Shifting Focus: The Relationship with Yo...
Let's Talk About It: Ovarian Cancer (Shifting Focus: The Relationship with Yo...
 
Ways to Manage Ovarian Cancer Treatment Side Effects
Ways to Manage Ovarian Cancer Treatment Side EffectsWays to Manage Ovarian Cancer Treatment Side Effects
Ways to Manage Ovarian Cancer Treatment Side Effects
 
Part II: DCIS Research: De-escalating the Fear of Recurrence
Part II: DCIS Research: De-escalating the Fear of RecurrencePart II: DCIS Research: De-escalating the Fear of Recurrence
Part II: DCIS Research: De-escalating the Fear of Recurrence
 
Report Back from San Antonio Breast Cancer Symposium (SABCS) 2023: Spotlight ...
Report Back from San Antonio Breast Cancer Symposium (SABCS) 2023: Spotlight ...Report Back from San Antonio Breast Cancer Symposium (SABCS) 2023: Spotlight ...
Report Back from San Antonio Breast Cancer Symposium (SABCS) 2023: Spotlight ...
 
Sharing Our Own Experience- A Qualitative Study with Black Women Diagnosed wi...
Sharing Our Own Experience- A Qualitative Study with Black Women Diagnosed wi...Sharing Our Own Experience- A Qualitative Study with Black Women Diagnosed wi...
Sharing Our Own Experience- A Qualitative Study with Black Women Diagnosed wi...
 
Part I: Not all DCIS is "Risky"
Part I: Not all DCIS is "Risky"Part I: Not all DCIS is "Risky"
Part I: Not all DCIS is "Risky"
 

Recently uploaded

pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...
pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...
pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...Call Girls Noida
 
Udaipur Call Girls 📲 9999965857 Call Girl in Udaipur
Udaipur Call Girls 📲 9999965857 Call Girl in UdaipurUdaipur Call Girls 📲 9999965857 Call Girl in Udaipur
Udaipur Call Girls 📲 9999965857 Call Girl in Udaipurseemahedar019
 
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋Sheetaleventcompany
 
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near MeVIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Memriyagarg453
 
indian Call Girl Panchkula ❤️🍑 9907093804 Low Rate Call Girls Ludhiana Tulsi
indian Call Girl Panchkula ❤️🍑 9907093804 Low Rate Call Girls Ludhiana Tulsiindian Call Girl Panchkula ❤️🍑 9907093804 Low Rate Call Girls Ludhiana Tulsi
indian Call Girl Panchkula ❤️🍑 9907093804 Low Rate Call Girls Ludhiana TulsiHigh Profile Call Girls Chandigarh Aarushi
 
Local Housewife and effective ☎️ 8250192130 🍉🍓 Sexy Girls VIP Call Girls Chan...
Local Housewife and effective ☎️ 8250192130 🍉🍓 Sexy Girls VIP Call Girls Chan...Local Housewife and effective ☎️ 8250192130 🍉🍓 Sexy Girls VIP Call Girls Chan...
Local Housewife and effective ☎️ 8250192130 🍉🍓 Sexy Girls VIP Call Girls Chan...Russian Call Girls Amritsar
 
Call Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In Faridabad
Call Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In FaridabadCall Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In Faridabad
Call Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In Faridabadgragmanisha42
 
Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...
Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...
Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...Niamh verma
 
No Advance 9053900678 Chandigarh Call Girls , Indian Call Girls For Full Ni...
No Advance 9053900678 Chandigarh  Call Girls , Indian Call Girls  For Full Ni...No Advance 9053900678 Chandigarh  Call Girls , Indian Call Girls  For Full Ni...
No Advance 9053900678 Chandigarh Call Girls , Indian Call Girls For Full Ni...Vip call girls In Chandigarh
 
Call Girl Price Amritsar ❤️🍑 9053900678 Call Girls in Amritsar Suman
Call Girl Price Amritsar ❤️🍑 9053900678 Call Girls in Amritsar SumanCall Girl Price Amritsar ❤️🍑 9053900678 Call Girls in Amritsar Suman
Call Girl Price Amritsar ❤️🍑 9053900678 Call Girls in Amritsar SumanCall Girls Service Chandigarh Ayushi
 
💚😋Kolkata Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Kolkata Escort Service Call Girls, ₹5000 To 25K With AC💚😋💚😋Kolkata Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Kolkata Escort Service Call Girls, ₹5000 To 25K With AC💚😋Sheetaleventcompany
 
VIP Kolkata Call Girl New Town 👉 8250192130 Available With Room
VIP Kolkata Call Girl New Town 👉 8250192130  Available With RoomVIP Kolkata Call Girl New Town 👉 8250192130  Available With Room
VIP Kolkata Call Girl New Town 👉 8250192130 Available With Roomdivyansh0kumar0
 
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...Call Girls Noida
 
Dehradun Call Girls Service 08854095900 Real Russian Girls Looking Models
Dehradun Call Girls Service 08854095900 Real Russian Girls Looking ModelsDehradun Call Girls Service 08854095900 Real Russian Girls Looking Models
Dehradun Call Girls Service 08854095900 Real Russian Girls Looking Modelsindiancallgirl4rent
 
Call Now ☎ 9999965857 !! Call Girls in Hauz Khas Escort Service Delhi N.C.R.
Call Now ☎ 9999965857 !! Call Girls in Hauz Khas Escort Service Delhi N.C.R.Call Now ☎ 9999965857 !! Call Girls in Hauz Khas Escort Service Delhi N.C.R.
Call Now ☎ 9999965857 !! Call Girls in Hauz Khas Escort Service Delhi N.C.R.ktanvi103
 
❤️♀️@ Jaipur Call Girls ❤️♀️@ Jaispreet Call Girl Services in Jaipur QRYPCF ...
❤️♀️@ Jaipur Call Girls ❤️♀️@ Jaispreet Call Girl Services in Jaipur QRYPCF  ...❤️♀️@ Jaipur Call Girls ❤️♀️@ Jaispreet Call Girl Services in Jaipur QRYPCF  ...
❤️♀️@ Jaipur Call Girls ❤️♀️@ Jaispreet Call Girl Services in Jaipur QRYPCF ...Gfnyt.com
 
VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591
VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591
VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591adityaroy0215
 
VIP Call Girl Sector 32 Noida Just Book Me 9711199171
VIP Call Girl Sector 32 Noida Just Book Me 9711199171VIP Call Girl Sector 32 Noida Just Book Me 9711199171
VIP Call Girl Sector 32 Noida Just Book Me 9711199171Call Girls Service Gurgaon
 
Krishnagiri call girls Tamil aunty 7877702510
Krishnagiri call girls Tamil aunty 7877702510Krishnagiri call girls Tamil aunty 7877702510
Krishnagiri call girls Tamil aunty 7877702510Vipesco
 

Recently uploaded (20)

pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...
pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...
pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...
 
Udaipur Call Girls 📲 9999965857 Call Girl in Udaipur
Udaipur Call Girls 📲 9999965857 Call Girl in UdaipurUdaipur Call Girls 📲 9999965857 Call Girl in Udaipur
Udaipur Call Girls 📲 9999965857 Call Girl in Udaipur
 
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋
 
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near MeVIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
 
indian Call Girl Panchkula ❤️🍑 9907093804 Low Rate Call Girls Ludhiana Tulsi
indian Call Girl Panchkula ❤️🍑 9907093804 Low Rate Call Girls Ludhiana Tulsiindian Call Girl Panchkula ❤️🍑 9907093804 Low Rate Call Girls Ludhiana Tulsi
indian Call Girl Panchkula ❤️🍑 9907093804 Low Rate Call Girls Ludhiana Tulsi
 
Local Housewife and effective ☎️ 8250192130 🍉🍓 Sexy Girls VIP Call Girls Chan...
Local Housewife and effective ☎️ 8250192130 🍉🍓 Sexy Girls VIP Call Girls Chan...Local Housewife and effective ☎️ 8250192130 🍉🍓 Sexy Girls VIP Call Girls Chan...
Local Housewife and effective ☎️ 8250192130 🍉🍓 Sexy Girls VIP Call Girls Chan...
 
Call Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In Faridabad
Call Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In FaridabadCall Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In Faridabad
Call Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In Faridabad
 
Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...
Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...
Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...
 
No Advance 9053900678 Chandigarh Call Girls , Indian Call Girls For Full Ni...
No Advance 9053900678 Chandigarh  Call Girls , Indian Call Girls  For Full Ni...No Advance 9053900678 Chandigarh  Call Girls , Indian Call Girls  For Full Ni...
No Advance 9053900678 Chandigarh Call Girls , Indian Call Girls For Full Ni...
 
Call Girl Price Amritsar ❤️🍑 9053900678 Call Girls in Amritsar Suman
Call Girl Price Amritsar ❤️🍑 9053900678 Call Girls in Amritsar SumanCall Girl Price Amritsar ❤️🍑 9053900678 Call Girls in Amritsar Suman
Call Girl Price Amritsar ❤️🍑 9053900678 Call Girls in Amritsar Suman
 
💚😋Kolkata Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Kolkata Escort Service Call Girls, ₹5000 To 25K With AC💚😋💚😋Kolkata Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Kolkata Escort Service Call Girls, ₹5000 To 25K With AC💚😋
 
VIP Kolkata Call Girl New Town 👉 8250192130 Available With Room
VIP Kolkata Call Girl New Town 👉 8250192130  Available With RoomVIP Kolkata Call Girl New Town 👉 8250192130  Available With Room
VIP Kolkata Call Girl New Town 👉 8250192130 Available With Room
 
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...
 
Dehradun Call Girls Service 08854095900 Real Russian Girls Looking Models
Dehradun Call Girls Service 08854095900 Real Russian Girls Looking ModelsDehradun Call Girls Service 08854095900 Real Russian Girls Looking Models
Dehradun Call Girls Service 08854095900 Real Russian Girls Looking Models
 
Call Now ☎ 9999965857 !! Call Girls in Hauz Khas Escort Service Delhi N.C.R.
Call Now ☎ 9999965857 !! Call Girls in Hauz Khas Escort Service Delhi N.C.R.Call Now ☎ 9999965857 !! Call Girls in Hauz Khas Escort Service Delhi N.C.R.
Call Now ☎ 9999965857 !! Call Girls in Hauz Khas Escort Service Delhi N.C.R.
 
❤️♀️@ Jaipur Call Girls ❤️♀️@ Jaispreet Call Girl Services in Jaipur QRYPCF ...
❤️♀️@ Jaipur Call Girls ❤️♀️@ Jaispreet Call Girl Services in Jaipur QRYPCF  ...❤️♀️@ Jaipur Call Girls ❤️♀️@ Jaispreet Call Girl Services in Jaipur QRYPCF  ...
❤️♀️@ Jaipur Call Girls ❤️♀️@ Jaispreet Call Girl Services in Jaipur QRYPCF ...
 
VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591
VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591
VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591
 
VIP Call Girl Sector 32 Noida Just Book Me 9711199171
VIP Call Girl Sector 32 Noida Just Book Me 9711199171VIP Call Girl Sector 32 Noida Just Book Me 9711199171
VIP Call Girl Sector 32 Noida Just Book Me 9711199171
 
Krishnagiri call girls Tamil aunty 7877702510
Krishnagiri call girls Tamil aunty 7877702510Krishnagiri call girls Tamil aunty 7877702510
Krishnagiri call girls Tamil aunty 7877702510
 
Model Call Girl in Subhash Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Subhash Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Subhash Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Subhash Nagar Delhi reach out to us at 🔝9953056974🔝
 

Clinical Trials for Metastatic Breast Cancer

  • 1. Courtney Hudson, CEO & Founder, EmergingMedJune 26, 2017 FACT VS FICTION: CLINICAL TRIALS FOR OVARIAN CANCER FACT vs. FICTION CLINICAL TRIALS FOR BREAST CANCER
  • 2. Agenda 1. How to search for clinical trials? 2. What’s out there? 3. About targeted therapies & tumor profiling 4. Considerations for phase I clinical trials 5. Discussion & questions 2 www.ShareCancerSupport.org 1.877.769.4832
  • 3. Today’s goal is to empower you with information and a strategy to explore and access breast cancer clinical trials Create a profile team up with a Navigator How to search for trials?3 www.ShareCancerSupport.org 1.877.769.4832
  • 4. SHARE Clinical Trial Matching Service 4 www.ShareCancerSupport.org 1.877.769.4832 1) Complete profile 2) Update profile 3) Review matches with Clinical Trial Navigator 4) Talk to trial site(s) 5) Discuss with your doctor
  • 5. Never forget... ¨ Clinical trials may or may not be right for you v Standard care vs. clinical trial vs. off label treatment vs. watch & wait ¨ Explore clinical trials each time you make a treatment decision ¨ You are NEVER required to enroll in a clinical trial ¨ You are NEVER required to remain in a clinical trial after you enroll 5 www.ShareCancerSupport.org 1.877.769.4832
  • 6. Clinical trials measure, measure, measure 6 LESSONS Childhood Leukemia LEARNED Breast Cancer– BMT & HDC ¨ Clinical trials explore risk/benefit of new therapies: v New drug OR combination OR dosage/sequence ¨ Is experimental therapy better/worse vs. standard placebo ¨ Phases: I, II, III have become I/II, II, II/III, etc. ¨ Eligibility: v Diagnosis, stage, treatment history v And now tumor biomarkers…Tomorrow? ¨ Interim analysis
  • 7. Notes Clinical trials expect you to receive standard of care (vs. off label) Narrow window of time to enroll What’s out there for metastatic breast cancer treatment trials? as of 6/23/2017 7 www.ShareCancerSupport.org 1.877.769.4832
  • 8. Ø 50 unique drugs Ø 25 targeted agents (hitting 40 alterations) Ø 16 chemotherapies Ø 9 hormonal therapies Ø 2 immunotherapies target PD1 and PDL1 261 studies for metastatic breast cancer www.ShareCancerSupport.org 1.877.769.4832
  • 9. Clinical trials offered at all points (newly diagnosed --> many treatments) 9
  • 10. About targeted therapies & genomic profiling ¨ Identify biomarkers or genomic alterations specific to your tumor ¨ May or may not point you to a clinical trial today ¨ May provide information useful to you tomorrow v Check back periodically for new research and targeted agents specific to your tumor’s molecular or genetic profile v Big question: do tumor’s change over time? www.ShareCancerSupport.org 1.877.769.4832 10
  • 11. Ø Phase I trials are the first time a new therapy, a new combination, or a new dosage schedule is offered to patients Ø Hundreds of new targeted therapies and immunotherapies are entering Phase I trials Ø These new opportunities raise new questions Considerations for Phase I Trials11 www.ShareCancerSupport.org 1.877.769.4832
  • 12. Phase I, first-in-human trials & targeted therapies 12 ¨ Anti-cancer activity is now a goal in Phase I trials v Safety &maximum dose used to be only focus ¨ 70% of all agents in Phase I move on to Phase II v In 2000, only 10% moved on to Phase II trials ¨ Over 700 new agents in Phase I cancer studies today v Only 45 specifically mention ovarian cancer v Look for roll over studies: Phase I/II or II/III v May need to become patient of the investigator to get enrolled in a Phase I trial (limited openings, limited sites) ¨ Always ask: how many patients have had the new therapy before you in a Phase I study (none? 1? 10? 100?) www.ShareCancerSupport.org 1.877.769.4832
  • 13. Courtney Hudson CEO & Founder, EmergingMed chudson@emergingmed.com To search for trials and get registered: www.ShareCancerSupport.org 1.877.769.4832 Thank you and good luck13